Citalopram hydrobromi and 2 more items
Open Solicitation Posted
- Solicitation number
- SPE2DP27T0351
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- More information
Notice details come from DLA DIBBS. Updated .
About this opportunity
Defense Logistics Agency Troop Support Medical seeks quotes under request for quotation SPE2DP27T0351 for citalopram hydrobromide tablets, NSN 6505-01-505-4632, with quotes due November 18, 2026 via DIBBS. The solicitation is a Fast Auto Evaluation simplified acquisition carrying No Set-Aside Used, under PSC 6505 and NAICS 325412 as stated in the attachment summary.
Per the attachment summary, delivery is to Fort Stewart, Georgia and Fort Bliss, Texas. The requirement covers three line items totaling 5 bottles of 100-count, 20 mg tablets (1, 2, and 2 bottles under PRs 7019117298, 7019116533, and 7019116532), with delivery within 20 days, FOB Destination, and inspection at destination. Quantity ranges are encouraged to allow flexibility in award.
The item is FDA-regulated and requires a 36-month shelf life that is non-extendable, with Type I shelf-life marking under Medical Marking Standard No. 1. Packaging must comply with MIL-STD-2073-1E under special packaging instructions MPPWN00001, using commercial packaging and sealed unit containers. Shipments must be traceable and marked with the required Material Safety Data Sheet information. The attachment summary lists three approved manufacturers: Mylan Pharmaceuticals Inc (CAGE 3KJG9), Allergan USA Inc (CAGE 4END5), and Golden State Medical Supply Inc (CAGE 1HT23). DFARS 252.225-7001 (Buy American and Balance of Payments Program) applies.
Quotes must be submitted through DIBBS, and the solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions, Revision 106, dated November 3, 2026. Micro-purchase quotations may be awarded before the return date. The notice states no evaluation criteria, contract value, or incumbent.
Notice text
DLA request for quotation SPE2DP27T0351, issued by DLA office SPE2DP through DIBBS. Quotes are due by 11/18/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Items: line 0001, CITALOPRAM HYDROBROMI, NSN 6505-01-505-4632, 1 BT, delivery in 20 days, PR 7019117298; line 0002, CITALOPRAM HYDROBROMI, NSN 6505-01-505-4632, 2 BT, delivery in 20 days, PR 7019116533; line 0003, CITALOPRAM HYDROBROMI, NSN 6505-01-505-4632, 2 BT, delivery in 20 days, PR 7019116532. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DP27T0351.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Zolmitriptan tablet | Medical Supply Chain | No set-aside | |
| Sumatriptan succinate and 1 more item | Medical Supply Chain | No set-aside | |
| Famotidine tablets | Medical Supply Chain | No set-aside | |
| Omeprazole extended-R | Medical Supply Chain | No set-aside | |
| Suzetrigine tablets | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity